Trade

with

Opexa Therapeutics Inc
(NASDAQ: OPXA)
AdChoices
0.9700
+0.0872
+9.88%
After Hours :
-
-
-

Open

0.8900

Previous Close

0.8828

Volume (Avg)

205.47k (197.63k)

Day's Range

0.8800-0.9899

52Wk Range

0.7315-2.56

Market Cap.

24.50M

Dividend Rate ( Yield )

-

Beta

2.05

Shares Outstanding

27.75M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 1.27M

    • Net Income

    • -16.66M

    • Market Cap.

    • 24.50M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1,277.60

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.05

    • Forward P/E

    • -

    • Price/Sales

    • 15.22

    • Price/Book Value

    • 1.81

    • Price/Cash flow

    • -1.47

      • EBITDA

      • -14.05M

      • Return on Capital %

      • -124.68

      • Return on Equity %

      • -232.31

      • Return on Assets %

      • -124.68

      • Book Value/Share

      • 0.49

      • Shares Outstanding

      • 27.75M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 4.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -11.80

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -1,277.60

            • 39.38

            • Net Profit Margin

            • -1,277.60

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 4.79

              • 2.92

              • Quick Ratio

              • 4.39

              • 2.35

              • Interest Coverage

              • -48.97

              • 38.02

              • Leverage Ratio

              • 1.41

              • 2.21

              • Book Value/Share

              • 0.49

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.17

                • 238.10

                • P/E Ratio 5-Year High

                • -17.64

                • 634.30

                • P/E Ratio 5-Year Low

                • -0.99

                • 124.82

                • Price/Sales Ratio

                • 14.99

                • 8.94

                • Price/Book Value

                • 1.78

                • 8.12

                • Price/Cash Flow Ratio

                • -1.47

                • 47.85

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -232.31

                        (-111.00)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -124.68

                        (-89.60)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -227.66

                        (-113.30)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • 0.10

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -11.92M
                      Operating Margin
                      -941.33
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -1.47
                      Ownership

                      Institutional Ownership

                      4.48%

                      Top 10 Institutions

                      4.36%

                      Mutual Fund Ownership

                      2.57%

                      Float

                      97.15%

                      5% / Insider Ownership

                      77.21%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        383,605

                      • 0.00

                      • 1.38

                      • Vanguard Extended Market Index Fund

                      •  

                        248,172

                      • 3.22

                      • 0.89

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        68,287

                      • 0.00

                      • 0.25

                      • Fidelity Spartan® Total Market Idx Fund

                      •  

                        5,726

                      • 0.00

                      • 0.02

                      • AXA/Lord Abbett Micro Cap Portfolio

                      •  

                        4,669

                      • 0.00

                      • 0.02

                      • Wilshire Micro-Cap ETF

                      •  

                        3,068

                      • 0.00

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Group, Inc.

                      •  

                        624,040

                      • 0.00%

                      • 2.26

                      • California Public Employees Retrmnt Sys

                      •  

                        266,050

                      • 0.00%

                      • 0.96

                      • GRT Capital Partners LLC

                      •  

                        116,300

                      • +19.28%

                      • 0.42

                      • Geode Capital Management, LLC

                      •  

                        74,013

                      • 0.00%

                      • 0.27

                      • Northern Trust Investments, N.A.

                      •  

                        45,117

                      • 0.00%

                      • 0.16

                      • Moors & Cabot Inc

                      •  

                        31,000

                      • +93.75%

                      • 0.11

                      • Guggenheim Capital LLC

                      •  

                        10,208

                      • -9.08%

                      • 0.04

                      • Goldman, Sachs & Co.

                      •  

                        10,190

                      • -42.50%

                      • 0.04

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Value

                      Opexa Therapeutics, Inc., formerly known as PharmaFrontiers Corp., was incorporated in Texas in March 1991. The Company’s therapy is based on its proprietary T-cell technology. Opexa initiated a Phase IIb clinical trial of Tcelna in patients with secondary progressive multiple sclerosis. Tcelna has received Fast Track designation from the FDA in secondary progressive multiple sclerosis. Tcelna’s combats the demyelination of the nerve fibers in the central nervous system, the underlying cause of multiple sclerosis. The Company faces competition from pharmaceutical and biotechnology companies, as well as numerous academic and research institutions and governmental agencies in the United States and abroad.

                      Key People

                      Neil K. Warma

                      CEO/Director/President

                      Mr. Karthik Radhakrishnan

                      CFO/Chief Accounting Officer

                      Michael S. Richman

                      Director

                      Scott B. Seaman

                      Director

                      Timothy C. Barabe

                      Director

                      • Opexa Therapeutics Inc

                      • 2635 Technology Forest Boulevard

                      • The Woodlands, TX 77381

                      • USA.Map

                      • Phone: +1 281 775-060

                      • Fax: +1 281 872-8585

                      • opexatherapeutics.com

                      Incorporated

                      1991

                      Employees

                      38

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: